Literature DB >> 12135995

Prescription habits of dispensing and non-dispensing doctors in Zimbabwe.

Birna Trap1, Ebba Holme Hansen, Hans V Hogerzeil.   

Abstract

The number of dispensing doctors has increased in the last decade, but the implication of this trend on the quality of health care and drug use is unknown. We present a comparative drug utilization study of 29 dispensing doctors and 28 non-dispensing doctors in Zimbabwe based on standard indicators developed by the World Health Organization. Dispensing doctors prescribed significantly more drugs per patient than non-dispensing doctors (2.3 versus 1.7), injected more patients (28.4% versus 9.5%), and prescribed more antibiotics (0.72 versus 0.54) and mixtures (0.43 versus 0.25) per encounter. Dispensing doctors also spent significantly less time on each encounter (8.7 min versus 13.0 min) than their non-dispensing colleagues. The use of generic name, brand name and essential drugs did not differ significantly between the two groups of practitioners. Multivariate analyses controlling for gender, race, place of education, location of practice and patients seen per day showed that dispensing by doctors was associated with less clinically and economically appropriate prescribing. These findings suggest that the quality of health care--as related to drug use, patient safety and treatment cost--is lower with dispensing doctors than with non-dispensing doctors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135995     DOI: 10.1093/heapol/17.3.288

Source DB:  PubMed          Journal:  Health Policy Plan        ISSN: 0268-1080            Impact factor:   3.344


  22 in total

1.  Pharmaceutical policy and the pharmacy profession.

Authors:  Janine M Traulsen; Anna Birna Almarsdóttir
Journal:  Pharm World Sci       Date:  2005-10

2.  Patterns of prescription and drug dispensing.

Authors:  Sunil Karande; Punam Sankhe; Madhuri Kulkarni
Journal:  Indian J Pediatr       Date:  2005-02       Impact factor: 1.967

3.  Challenges of drug risk communications in the Philippines.

Authors:  Kenneth Hartigan-Go
Journal:  Drug Saf       Date:  2012-11-01       Impact factor: 5.606

4.  Benzodiazepine prescribing behaviour and attitudes: a survey among general practitioners practicing in northern Thailand.

Authors:  Manit Srisurapanont; Paul Garner; Julia Critchley; Nahathai Wongpakaran
Journal:  BMC Fam Pract       Date:  2005-06-23       Impact factor: 2.497

5.  Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.

Authors:  Zaheer Ud Din Babar; Mohamed Izham Mohamed Ibrahim; Harpal Singh; Nadeem Irfan Bukahri; Andrew Creese
Journal:  PLoS Med       Date:  2007-03-27       Impact factor: 11.069

6.  Effects of the expansion of doctors' offices adjacent to private pharmacies in Mexico: secondary data analysis of a national survey.

Authors:  Ricardo Pérez-Cuevas; Svetlana V Doubova; Veronika J Wirtz; Edson Servan-Mori; Anahí Dreser; Mauricio Hernández-Ávila
Journal:  BMJ Open       Date:  2014-05-22       Impact factor: 2.692

7.  Prescription pattern and its influencing factors in Chinese county hospitals: a retrospective cross-sectional study.

Authors:  Heng Wang; Niannian Li; Haidi Zhu; Shuman Xu; Hua Lu; ZhanChun Feng
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

Review 8.  A review of injection and antibiotic use at primary health care (public and private) centers in Africa.

Authors:  Richard Ofori-Asenso; Akosua Adom Agyeman
Journal:  J Pharm Bioallied Sci       Date:  2015 Jul-Sep

9.  WHO essential medicines policies and use in developing and transitional countries: an analysis of reported policy implementation and medicines use surveys.

Authors:  Kathleen Anne Holloway; David Henry
Journal:  PLoS Med       Date:  2014-09-16       Impact factor: 11.069

10.  The Impact of WHO Essential Medicines Policies on Inappropriate Use of Antibiotics.

Authors:  Kathleen Anne Holloway; Laura Rosella; David Henry
Journal:  PLoS One       Date:  2016-03-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.